We are live on ! Find out more
PFM

Premier Fund Managers Portfolio holdings

AUM $1.1B
1-Year Est. Return 14.42%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+14.42%
3 Year Est. Return
+56.59%
5 Year Est. Return
+84.57%
10 Year Est. Return
+434.11%
AUM
$2.53B
AUM Growth
-$40.3M
Cap. Flow
-$34.1M
Cap. Flow %
-1.35%
Top 10 Hldgs %
22.75%
Holding
246
New
45
Increased
28
Reduced
88
Closed
24

Top Buys

Rank Stock Value
1
AJG icon
Arthur J. Gallagher & Co
AJG
+$47.4M
2
IEX icon
IDEX
IEX
+$45.4M
3
MSFT icon
Microsoft
MSFT
+$11.7M
4
UNP icon
Union Pacific
UNP
+$11.3M
5
CRM icon
Salesforce
CRM
+$10.4M

Top Sells

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$38M
2
HCA icon
HCA Healthcare
HCA
+$15M
3
ES icon
Eversource Energy
ES
+$12M
4
CTVA icon
Corteva
CTVA
+$9.85M
5
MRK icon
Merck
MRK
+$9.12M

Sector Composition

Rank Sector Weight
1 Industrials 25.19%
2 Financials 17.75%
3 Consumer Discretionary 13.05%
4 Healthcare 12.42%
5 Technology 11.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLFS icon
176
BioLife Solutions
BLFS
$1.82B
$959K 0.04%
46,175
-20,006
-30% -$450K
SMAR
177
DELISTED
Smartsheet Inc.
SMAR
$951K 0.04%
+20,404
New +$888K
ACCD
178
DELISTED
Accolade Inc
ACCD
$936K 0.04%
+69,022
New +$781K
LOVE
179
LoveSac
LOVE
$235M
$912K 0.04%
33,082
-25,216
-43% -$666K
VCYT icon
180
Veracyte
VCYT
$3.64B
$909K 0.04%
44,176
TREX icon
181
Trex
TREX
$4.69B
$906K 0.04%
+19,462
New +$984K
MET icon
182
MetLife
MET
$61.2B
$880K 0.03%
15,432
GILD icon
183
Gilead Sciences
GILD
$185B
$869K 0.03%
10,664
+1,518
+17% +$126K
MXCT icon
184
MaxCyte
MXCT
$132M
$868K 0.03%
184,872
-70,523
-28% -$347K
ESMT
185
DELISTED
EngageSmart, Inc.
ESMT
$865K 0.03%
+46,023
New +$890K
KEX icon
186
Kirby Corp
KEX
$7.38B
$851K 0.03%
12,450
-4,350
-26% -$300K
EVBG
187
DELISTED
Everbridge, Inc. Common Stock
EVBG
$850K 0.03%
+25,565
New +$817K
MAX icon
188
MediaAlpha
MAX
$666M
$849K 0.03%
+58,870
New +$796K
OLO
189
DELISTED
Olo Inc
OLO
$820K 0.03%
+104,355
New +$803K
AMGN icon
190
Amgen
AMGN
$236B
$811K 0.03%
3,360
PG icon
191
Procter & Gamble
PG
$333B
$811K 0.03%
5,500
KO icon
192
Coca-Cola
KO
$383B
$804K 0.03%
13,000
MRK icon
193
Merck
MRK
$369B
$795K 0.03%
7,500
-84,500
-92% -$9.12M
BL icon
194
BlackLine
BL
$1.96B
$771K 0.03%
+11,914
New +$821K
INMD icon
195
InMode
INMD
$854M
$770K 0.03%
+24,426
New +$837K
WING icon
196
Wingstop
WING
$3B
$767K 0.03%
+4,269
New +$701K
TKNO icon
197
Alpha Teknova
TKNO
$392M
$763K 0.03%
265,934
XPOF icon
198
Xponential Fitness
XPOF
$228M
$755K 0.03%
+25,764
New +$682K
TCMD icon
199
Tactile Systems Technology
TCMD
$523M
$727K 0.03%
+44,192
New +$615K
NVMI
200
Nova
NVMI
$11.8B
$723K 0.03%
7,010

Similar funds

Premier Fund Managers's Q1 2023 Portfolio in Review

As of Q1 2023, Premier Fund Managers held 246 positions worth $2.53B, down 1.6% from $2.57B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Premier Fund Managers's Q1 2023 filing shows 45 new, 28 increased, 88 reduced and 24 closed positions. Its largest new stake was Arthur J. Gallagher & Co: 250,000 shares worth $47.4M. The largest sale was Universal Health Services, an estimated $38M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Premier Fund Managers's largest Q1 2023 buy was Arthur J. Gallagher & Co: 250,000 shares worth $47.4M.
  • Premier Fund Managers added most to Microsoft in Q1 2023, an estimated $11.7M increase.
  • Premier Fund Managers's biggest Q1 2023 reduction was HCA Healthcare, cutting an estimated $15M.
  • Premier Fund Managers fully exited Universal Health Services in Q1 2023, selling an estimated $38M.
  • Premier Fund Managers's ten largest holdings make up 23% of its $2.53B portfolio in Q1 2023.
  • Premier Fund Managers opened 45 new positions and closed 24 in Q1 2023.
  • Premier Fund Managers's portfolio value fell 1.6% quarter-over-quarter to $2.53B.

Based on Premier Fund Managers's 13F filing for Q1 2023, filed 5 May 2023.